IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma
Author:
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference62 articles.
1. Emerging evidence of molecular biomarkers in hepatocellular carcinoma.;Umeda;Histol. Histopathol.,2018
2. Components of the hepatocellular carcinoma microenvironment and their role in tumor progression.;Novikova;Biochemistry (Mosc.),2017
3. New horizons in tumor microenvironment biology: challenges and opportunities
4. Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy.;Tahmasebi Birgani;Int. J. Mol. Sci.,2017
5. The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma;Current Cancer Drug Targets;2024-11
2. IL-33 and IL-33-derived DC-based tumor immunotherapy;Experimental & Molecular Medicine;2024-06-03
3. Role of T cells in liver metastasis;Cell Death & Disease;2024-05-16
4. Unpacking the complexity of nuclear IL-33 (nIL-33): a crucial regulator of transcription and signal transduction;Journal of Cell Communication and Signaling;2023-10-25
5. Discovery of highly immunogenic spleen-resident FCGR3+CD103+ cDC1s differentiated by IL-33-primed ST2+ basophils;Cellular & Molecular Immunology;2023-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3